I have not made it a habit to write many personal updates on this blog. After all, who really wants to read about what I had for dinner and what I got up to at the weekend? Well maybe you do. So here’s a quick round-up of what I’ve been up to.
Indian scotch eggs
Where I live in at the moment, I’m lucky enough to have an incredible selection of Indian restaurants right on my doorstep. And just the other week, a new one popped up in the village with an interesting USP.
‘Eggs & More’ is a vegetarian restaurant that specialises in dishes containing eggs. Now, I have always been a fan of the traditional scotch egg but never in my wildest dreams did I think I would see it on the menu at an Indian restaurant. So this was something I just had to try.
They were like traditional scotch eggs but with potato and spices instead of sausage meat.
As well as the scotch eggs I also had a dish called Boiled Kheema which was described as grated boiled eggs, cooked with onions, green chillies and a special gravy. A spicy, soupy delight. Who knew eggs could be so good?
Seeking Alpha articles
Apart from eating Indian food, some of you will know that I have been working on updates to the HTBWS course recently. This has left me with little time to do much else.
However, I did manage to write a couple of Seeking Alpha articles in which I mention two stocks that have shown some strong insider buying.
The first article talks about tractor manufacturer $AGCO which was recently downgraded by UBS analysts.
The second article has only just been published and concerns a microcap biotech stock called Alimera Sciences $ALIM.
See the full article here: Alimera Sciences: Insiders Buying This Biotech, Stock Sees Catalyst.
Although I don’t count myself as an expert biotech trader, I like to write these articles as a way of capturing a thought process and strategy.
In these two, I am specifically interested in the implications of insider purchases. And at a later date, I will be able to look back and see if these ideas would have made any money. And it’s going well so far, ALIM is already up 14% since I wrote the piece.
Carl Icahn sees danger ahead
Lastly, I came across a presentation from activist investor Carl Icahn at the weekend. Despite his advocacy for Donald Trump, Icahn’s view of the current ‘earnings mirage’ is interesting.
Icahn suggests that the quality of recent corporate earnings are ‘very suspect’. He suggests that companies are now engaging in acquisitions in order to show analysts on Wall Street that earnings are going up. But this is simply ‘financial engineering at it’s height‘.
He makes some strong points. If you have not already, I recommend you give it a watch.